Shandong Luoxin Pharmaceutical Group Stock Co Ltd ($8058) - buy or sell? Stock discussion, ideas, forum

Shandong Luoxin Pharmaceutical Group Stock Co Ltd

Shandong Luoxin Pharmaceutical Group Stock Company Limited manufactures pharmaceuticals.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$8058	HKEx GEM	CNE100000163	Code: 8058

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 8058 stock

Share your investment idea or question on Shandong Luoxin Pharmaceutical Group Stock Co Ltd stock:

Latest twits on Shandong Luoxin Pharmaceutical Group Stock Co Ltd (8058)

No twits yet. Be the first to post!

Have a question about 8058? Ask and other investors will be eager to help you.

Have an idea about 8058? Share it with other investors.

Shandong Luoxin Pharmaceutical Group Stock Co Ltd news

07/03/2017 Shandong Luoxin Pharmaceutical Group Stock Co Ltd reports 23.1% Net Income decline while 14.0% Revenue growth

29/03/2016 Shandong Luoxin Pharmaceutical Group Stock Co Ltd demonstrates profitable growth

22/03/2016 Shandong Luoxin Pharmaceutical Group Stock Co Ltd revenue jumped on 30.5% in 2015 while EBITDA Margin decreased slightly on 2.0 pp from 18.6% to 16.6%

Shandong Luoxin Pharmaceutical Group Stock Co Ltd stock price chart

Shandong Luoxin Pharmaceutical Group Stock Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	1,342	1,627	2,228
EBITDA	462.9	516.7	522.1
Net income	383.1	426.6	439.9
CAPEX	101.7	88.801	141.0
Debt	86.837	34.481	101.9
Cash	582.0	892.9	335.3

Shandong Luoxin Pharmaceutical Group Stock Co Ltd news

About Shandong Luoxin Pharmaceutical Group Stock Co Ltd

Shandong Luoxin Pharmaceutical Group Stock Company Limited manufactures pharmaceuticals. The Company produces antibiotics, anti-viral medicines, and system specific medicines.